Bahrain's First CRISPR Patient Rebuilds Life After Treatment

For the first time in his life, Amjad Kazem Ahmed can imagine playing football without fear of triggering a health crisis.

The 28-year-old Bahraini made medical history as his country's first patient to receive CRISPR gene-editing therapy for sickle cell disease, a painful hereditary blood disorder. While the groundbreaking treatment happened months ago, Amjad's real story is unfolding now in what he calls "the transition from illness to recovery."

Growing up with sickle cell meant watching life from the sidelines. Swimming, running, and sports were off-limits because pushing his body too hard could trigger dangerous complications. "I was deprived of many things, because pushing myself could make me sick," he told The Daily Tribune in Manama.

The treatment itself was grueling. Amjad underwent a bone marrow transplant using CRISPR technology, which edits genes to correct the genetic mutation causing his disease. The procedure required intensive medical care and a lengthy recovery period that tested both his body and spirit.

Today, Amjad finds himself in unfamiliar territory. His condition has improved dramatically, but his body needs time to catch up with his ambitions. "Sometimes I get excited to do things, but then I'm surprised that my energy doesn't allow it," he explained.

He's tackling recovery the same way he survived his illness: one step at a time. Amjad now trains regularly, slowly rebuilding the physical strength that sickle cell stole from him over decades. Each workout brings him closer to activities he once thought impossible.

Why This Inspires

Amjad's journey reminds us that medical breakthroughs are just the beginning. The real courage shows up in the months and years after treatment, when patients must patiently rebuild their lives brick by brick. His determination to reclaim lost opportunities extends beyond physical health—he's pursuing his education with renewed ambition after illness delayed his studies for years.

Throughout his treatment, Amjad received support from Bahrain's medical team and even personal visits from Crown Prince Salman bin Hamad Al Khalifa. When they met again after a year, Amjad arrived in good health, a moment he described as "even better than the first."

His story offers hope to thousands living with sickle cell disease across the Middle East and beyond. CRISPR technology, once confined to laboratories, is now changing real lives in real time.

Amjad isn't celebrating a miracle cure—he's celebrating the chance to finally live without limits.